ArticleJournal of pharmacy & bioallied sciences2024
Periodontal Therapy as an Adjunct to Pulmonary Rehabilitation in Chronic Respiratory Diseases: A Randomized Controlled Trial.
Article in Journal of pharmacy & bioallied sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic respiratory diseases (CRDs) significantly impact quality of life and are linked to systemic inflammation. This study explores the potential connection between oral and respiratory health by investigating the benefits of integrating periodontal therapy into pulmonary rehabilitation (PR) for CRD patients. Objective: This randomized controlled trial (RCT) assessed the impact of periodontal therapy combined with PR on lung function, quality of life, and systemic inflammation in CRD patients. Methods: 2500 adults with CRDs and moderate to severe periodontal disease were randomized to receive standard PR or PR plus periodontal therapy. The primary outcome was the change in forced expiratory volume in one second (FEV1). Secondary outcomes included quality of life, inflammatory markers, and periodontal health parameters. Results: The combined therapy group showed significantly greater improvements in FEV1 ( Conclusion: Integrating periodontal therapy into PR programs provides additional benefits for CRD patients, suggesting a potential mechanism through which addressing periodontal inflammation positively impacts overall health. These findings support the inclusion of periodontal therapy as an adjunctive treatment strategy in CRD management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.